In the present study, we constructed CAIXpromotor controlled oncolytic adenovirus expressing AIM2 (Ad‐CAIXpromotor‐AIM2) and evaluated its efficacy and toxicity in renal cancer cells or tumour models. Here, AIM2 is linked to neoplasm.